Invention Grant
- Patent Title: Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient
- Patent Title (中): 卡巴糖胺衍生物和含有与活性成分相同的糖脂代谢紊乱处理剂
-
Application No.: US10793857Application Date: 2004-03-08
-
Publication No.: US07790773B2Publication Date: 2010-09-07
- Inventor: Seiichiro Ogawa , Yoshiyuki Suzuki , Eiji Nanba , Junichiro Matsuda , Kousaku Ohno
- Applicant: Seiichiro Ogawa , Yoshiyuki Suzuki , Eiji Nanba , Junichiro Matsuda , Kousaku Ohno
- Applicant Address: JP Tokyo
- Assignee: Seikagaku Corporation
- Current Assignee: Seikagaku Corporation
- Current Assignee Address: JP Tokyo
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2001-272775 20010907; JP2001-272776 20010907; JP2001-272777 20010907
- Main IPC: A61K31/133
- IPC: A61K31/133 ; C07C211/40 ; C07C215/44
Abstract:
A carba-sugar amine derivative represented by the following formula (1) or (2) is used as the active ingredient of a β-galactosidase inhibitor or a glycolipid metabolic disorder treating agent. Wherein each of R1 and R2 independently represents H, an alkyl group, an acyl group, an aryl group or an aralkyl group, with the proviso that both are not H at the same time, and each of R3, R4, R5 and R6 independently represents a hydroxyl group or hydroxyl group having a substituent.Also, R7 represents an alkyl group, and each of R8, R9, R10 and R11 independently represents a hydroxyl group or a hydroxyl group having a substituent.
Public/Granted literature
Information query
